Literature DB >> 31810962

HOXB2 is a Putative Tumour Promotor in Human Bladder Cancer.

Jia Liu1,2, Sheng Li2, Xiaojing Cheng1,2, Peng DU2, Yong Yang3, Wen G Jiang4.   

Abstract

BACKGROUND/AIM: The present study aimed to investigate the role of Homebox B2 (HOXB2) in bladder cancer (BC).
MATERIALS AND METHODS: The Cancer Genome Atlas (TCGA) dataset was used to analyse HOXB2 expression in BC. The influence of HOXB2 on the cellular functions of BC cells was determined in both HOXB2 knockdown and HOXB2 overexpressed BC cell lines using in vitro assays.
RESULTS: HOXB2 mRNA was significantly upregulated in luminal infiltrated and luminal papillary subtypes of BC. Drug Metabolism Cytochrome P450 was significantly enriched in BCs expressing high levels of HOXB2. Knockdown of HOXB2 from EJ138 cells reduced growth, adhesion and invasion. In contrast, overexpression of HOXB2 in RT112 cells induced growth and adhesion of bladder cancer cells.
CONCLUSION: Increased HOXB2 expression in papillary BC can promote cell growth and adhesion of BC cells. Drug Metabolism Cytochrome P450 pathway was enriched in BCs overexpressing HOXB2. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  HOXB2; bladder cancer; cytochrome P450; papillary tumour; proliferation

Year:  2019        PMID: 31810962     DOI: 10.21873/anticanres.13912

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer.

Authors:  Dirk Rades; Trang Nguyen; Steven E Schild
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2.

Authors:  Hailian Du; Ya'nan Bao; Chunying Liu; Anqiao Zhong; Yikai Niu; Xingping Tang
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

3.  The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.

Authors:  Deming Ou; Ying Wu
Journal:  BMC Cancer       Date:  2021-12-13       Impact factor: 4.430

4.  Identification of potential biomarkers in ovarian carcinoma and an evaluation of their prognostic value.

Authors:  Junyan Cai; Jiayi Qiu; Hongliang Wang; Jiacheng Sun; Yanan Ji
Journal:  Ann Transl Med       Date:  2021-09

5.  HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A.

Authors:  Xuelian Yang; Yuanhe Tong; Wenxia Ye; Lifen Chen
Journal:  Mol Med Rep       Date:  2022-03-22       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.